INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) of Class Action Lawsuit and Upcoming Deadlines

Pomerantz LLP announced a securities class action against iTonic Holdings (formerly Pheton Holdings), alleging that company officers, its auditor and IPO underwriters participated in a pump-and-dump scheme. The complaint alleges promoters used fabricated claims, including a rumored Gilead Sciences acquisition, to tout shares before the scheme unraveled on July 29, 2025, when the stock fell approximately 95% in one session. Investors who acquired shares during the class period have until September 28, 2026, to seek appointment as lead plaintiff.

Analysis

This is primarily a liquidity and governance event for ITOC, not a fundamental read-through for GILD. The litigation notice itself does not establish liability, but allegations involving promoters, auditors, and IPO underwriters raise the probability of prolonged disclosure, insurance-recovery, and exchange-compliance risk; for a thinly traded microcap, those risks can impair the ability to raise equity or retain market-maker support well before any legal resolution. The relevant near-term variable is not damages but whether management addresses the allegations with verifiable evidence, including ownership records, promotional-payment disclosures, related-party transactions, and cash balances.

A potential second-order effect is heightened diligence on similarly structured recent small-cap foreign issuer IPOs, particularly names with concentrated float, abrupt ticker/name changes, promotional volume spikes, or boutique underwriter/auditor overlap. That can widen liquidity discounts across the cohort for 1-3 months, though broad contagion is unlikely absent regulatory action. GILD should not trade on this item: fabricated acquisition speculation is reputationally noisy but has no identifiable earnings, pipeline, or M&A-process implication.

Consensus may overstate the informational value of a plaintiff-firm announcement after a major prior drawdown; these notices frequently follow price collapses and are not independent validation of the complaint. The bearish equity conclusion is therefore directionally sound but difficult to monetize through an outright short if borrow is scarce, financing is punitive, or the remaining float is dominated by momentum holders. A credible independent investigation, audited cash reconciliation, or regulatory clearance would be the key falsification and could trigger an extreme short-covering rally despite unresolved civil litigation.

Key Decisions for Investors

• Avoid initiating new long exposure to ITOC until the company provides independently verifiable disclosures on cash, related parties, promotional activity, and governance; treat any rebound before then as non-fundamental.
• For existing ITOC holdings, reduce or hedge exposure over the next days rather than waiting for the September 28 lead-plaintiff deadline; reassess only after a formal company response or exchange/regulatory filing. Residual-value and borrow constraints make a zero-style risk framework appropriate.
• Do not short ITOC outright without confirming borrow availability, borrow cost, average daily dollar volume, and locate stability; if all are favorable, use a small, tightly risk-capped tactical short over 1-3 months, covering on audited disclosure or a regulator-cleared update.
• Maintain no GILD position change on this news. Monitor only for a formal GILD statement or SEC-filed evidence of an actual transaction process; absent that, any sympathy move is a liquidity-driven opportunity to fade rather than an M&A signal.
• Screen comparable microcap IPOs for concentrated ownership, promotional-volume anomalies, repeat service-provider relationships, and weak cash-flow conversion; use this as a diligence alert, not a sector-wide short basket, unless enforcement or delisting actions broaden.